As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...
A surprising number of recent Bayesian phylogenetic analyses contain branch-length estimates that are several orders of magnitude longer than corresponding maximum-likelihood estimates. The levels of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results